Invention Grant
- Patent Title: Dihydropyrazole GPR40 modulators
-
Application No.: US14442670Application Date: 2013-11-15
-
Publication No.: US09604964B2Publication Date: 2017-03-28
- Inventor: Bruce A. Ellsworth , Jun Shi , William R. Ewing , Elizabeth A. Jurica , Andres S. Hernandez , Ximao Wu , Zhengxiang Gu , Zhenqiu Hong , Stephen P. O'Connor
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Barry H. Jacobsen; Yong Lu
- International Application: PCT/US2013/070216 WO 20131115
- International Announcement: WO2014/078611 WO 20140522
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D401/14 ; C07D405/12 ; C07D405/14 ; C07D417/14 ; C07D403/12 ; C07D451/06 ; A61K45/06 ; A61K31/4545 ; A61K31/4155 ; C07D413/14 ; C07D401/10 ; C07D487/08 ; A61K31/454 ; A61K31/46 ; A61K31/497 ; A61K31/506 ; A61K31/55 ; C07D471/08
Abstract:
The present invention provides compounds of Formula (I): (Formula (I), or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
Public/Granted literature
- US20160297797A1 DIHYDROPYRAZOLE GPR40 MODULATORS Public/Granted day:2016-10-13
Information query
